|
Felidae
|
B01.050.150.900.649.313.750.377.750 |
|
|
Chemotherapy-Related Cognitive Impairment
|
F03.615.250.700.250 |
|
|
Cognitive Dysfunction
|
F03.615.250.700 |
|
|
NAD
|
D08.211.589 |
|
|
Tenuazonic Acid
|
D23.946.587.915 |
|
|
Self Report
|
E05.318.308.980.500 |
|
|
Hope
|
F01.470.572 |
|
|
Chlorine
|
D01.268.380.150 |
|
|
Mice, Congenic
|
D020297 |
[Mouse strains constructed to possess identical genotypes except for a difference at a single gene locus.
] |
|
U937 Cells
|
D020298 |
[A human cell line established from a diffuse histiocytic lymphoma (HISTIOCYTIC LYMPHOMA, DIFFUSE) and displaying many monocytic characteristics. It serves as an in vitro model for MONOCYTE and MACROPHAGE differentiation.
] |
|
Ovarian Torsion
|
C23.300.970.625 |
|
|
Torsion Abnormality
|
C23.300.970 |
|
|
Brain Stem Neoplasms
|
D020295 |
[Benign and malignant intra-axial tumors of the MESENCEPHALON; PONS; or MEDULLA OBLONGATA of the BRAIN STEM. Primary and metastatic neoplasms may occur in this location. Clinical features include ATAXIA, cranial neuropathies (see CRANIAL NERVE DISEASES), NAUSEA, hemiparesis (see HEMIPLEGIA), and quadriparesis. Primary brain stem neoplasms are more frequent in children. Histologic subtypes include GLIOMA; HEMANGIOBLASTOMA; GANGLIOGLIOMA; and EPENDYMOMA.
] |
|
Animals, Congenic
|
D020296 |
[Animals that are produced through selective breeding to eliminate genetic background differences except for a single or few specific loci. They are used to investigate the contribution of genetic background differences to PHENOTYPE.
] |
|
Vasculitis, Central Nervous System
|
D020293 |
[Inflammation of blood vessels within the central nervous system. Primary vasculitis is usually caused by autoimmune or idiopathic factors, while secondary vasculitis is caused by existing disease process. Clinical manifestations are highly variable but include HEADACHE; SEIZURES; behavioral alterations; INTRACRANIAL HEMORRHAGES; TRANSIENT ISCHEMIC ATTACK; and BRAIN INFARCTION. (From Adams et al., Principles of Neurology, 6th ed, pp856-61)
] |
|
Myasthenic Syndromes, Congenital
|
D020294 |
[A heterogeneous group of disorders characterized by a congenital defect in neuromuscular transmission at the NEUROMUSCULAR JUNCTION. This includes presynaptic, synaptic, and postsynaptic disorders (that are not of autoimmune origin). The majority of these diseases are caused by mutations of various subunits of the nicotinic acetylcholine receptor (RECEPTORS, NICOTINIC) on the postsynaptic surface of the junction. (From Arch Neurol 1999 Feb;56(2):163-7)
] |
|
Prostaglandin H2
|
D044262 |
[A cyclic endoperoxide intermediate produced by the action of CYCLOOXYGENASE on ARACHIDONIC ACID. It is further converted by a series of specific enzymes to the series 2 prostaglandins.
] |
|
Receptors, Serotonin, 5-HT1
|
D044263 |
[A subclass of G-protein coupled SEROTONIN receptors that couple preferentially to GI-GO G-PROTEINS resulting in decreased intracellular CYCLIC AMP levels.
] |
|
Yttrium Radioisotopes
|
D01.496.749.960 |
|
|
Radioisotopes
|
D01.496.749 |
|
